Time to insulin initiation and long-term effects of initiating insulin in people with type 2 diabetes mellitus: the Hoorn Diabetes Care System Cohort Study

European Journal of Endocrinology
Ruth MastJacqueline G Hugtenburg

Abstract

The aim of this study was to assess the time to insulin initiation in type 2 diabetes mellitus (T2DM) patients treated with oral glucose-lowering agents and to determine the baseline characteristics associated with time to insulin initiation. This was evaluated in T2DM patients with HbA1c levels consistently ≥7.0% during total follow up and in those with fluctuating HbA1c levels around 7.0%. Prospective, observational study was performed, comprising 2418 persons with T2DM aged ≥40 years who entered the Diabetes Care System between 1998 and 2012 with a minimum follow up of at least 3 years, following the first HbA1c level ≥7.0%. Cox regression analyses were performed to assess the determinants of time to insulin initiation. Data related to long-term effects of insulin initiation were studied at baseline and at the end of follow up using descriptive summary statistics. Two-thirds of the patients initiated insulin during follow up. The time to insulin varied from 1.2 years (range 0.3-3.1) in patients with HbA1c levels consistently ≥7.0% to 5.4 years (range 3.0-7.5) in patients with fluctuating HbA1c levels around 7.0%. Longer diabetes duration (hazard ratio (HR) 1.04 95% CI 1.03-1.05) and lower age (HR 1.00 95% CI 0.99-1.00) at ba...Continue Reading

References

Jan 1, 1999·Lancet·M J Farthing
Aug 14, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M Korytkowski
Mar 21, 2007·Journal of General Internal Medicine·Gregory A NicholsSonali N Shah
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Jan 4, 2012·Diabetes Care·UNKNOWN American Diabetes Association
May 1, 2013·Current Vascular Pharmacology·Sibel Ertek, Sevki Cetinkalp
Oct 8, 2014·Acta Diabetologica·Iris WalravenGiel Nijpels

❮ Previous
Next ❯

Citations

Apr 19, 2018·Diabetes/metabolism Research and Reviews·Giuseppina T RussoUNKNOWN BetaDecline Study Group
Jan 21, 2018·Journal of General Internal Medicine·Scott J PillaNisa M Maruthur
Apr 23, 2020·Endocrinology, Diabetes & Metabolism·Anand Thakarakkattil Narayanan NairEwan R Pearson
Dec 14, 2019·Cardiovascular Diabetology·Roderick C SliekerJoline W J Beulens
Jul 15, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jian-Jun LiuSu Chi Lim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.